A computational model of transmembrane integrin clustering

Structure

Volumn 12, Issue 6, 2004, Pages 1109-1116

  Gottschalk, Kay Eberhard ^a   Kessler, Horst ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; INTEGRIN; MEMBRANE PROTEIN; PROTEIN SUBUNIT;

ARTICLE; GENE CLUSTER; GENE MUTATION; INDUCED MUTATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; CELL MEMBRANE; DIMERIZATION; DNA MUTATIONAL ANALYSIS; GLYCOPHORIN; HUMANS; INTEGRINS; MUTATION; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; SOFTWARE;

EID: 2942587504     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2004.02.039     Document Type: Article

References (49)

1. Adair B.D., Yeager M. Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and X-ray crystallography. Proc. Natl. Acad. Sci. USA. 99:2002;14059-14064
2. Adams P.D., Arkin I.T., Engelman D.M., Brunger A.T. Computational searching and mutagenesis suggest a structure for the pentameric transmembrane domain of phospholamban. Nat. Struct. Biol. 2:1995;154-162
3. Adams P.D., Engelman D.M., Brunger A.T. Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching. Proteins. 26:1996;257-261
4. Blystone S.D. Kinetic regulation of beta 3 integrin tyrosine phosphorylation. J. Biol. Chem. 277:2002;46886-46890
5. Boettiger D., Huber F., Lynch L., Blystone S. Activation of alpha(v)beta3-vitronectin binding is a multistage process in which increases in bond strength are dependent on Y747 and Y759 in the cytoplasmic domain of beta3. Mol. Biol. Cell. 12:2001;1227-1237. a
6. Boettiger D., Lynch L., Blystone S., Huber F. Distinct ligand-binding modes for integrin alpha(v)beta(3)-mediated adhesion to fibronectin versus vitronectin. J. Biol. Chem. 276:2001;31684-31690. b
7. Briggs J.A., Torres J., Arkin I.T. A new method to model membrane protein structure based on silent amino acid substitutions. Proteins. 44:2001;370-375
8. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921
9. Carman C.V., Springer T.A. Integrin avidity regulation. are changes in affinity and conformation underemphasized? Curr. Opin. Cell Biol. 15:2003;547-556
10. Choma C., Gratkowski H., Lear J.D., DeGrado W.F. Asparagine-mediated self-association of a model transmembrane helix. Nat. Struct. Biol. 7:2000;161-166
11. Dechantsreiter M.A., Planker E., Matha B., Lohof E., Holzemann G., Jonczyk A., Goodman S.L., Kessler H. N-methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J. Med. Chem. 42:1999;3033-3040
12. DeGrado W.F., Gratkowski H., Lear J.D. How do helix-helix interactions help determine the folds of membrane proteins? Perspectives from the study of homo-oligomeric helical bundles. Protein Sci. 12:2003;647-665
13. Eskens F.A., Dumez H., Hoekstra R., Perschl A., Brindley C., Bottcher S., Wynendaele W., Drevs J., Verweij J., van Oosterom A.T. Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours. Eur. J. Cancer. 39:2003;917-926
14. Fleming K.G., Engelman D.M. Computation and mutagenesis suggest a right-handed structure for the synaptobrevin transmembrane dimer. Proteins. 45:2001;313-317
15. Gottschalk K.E., Kessler H. The structures of integrins and integrin-ligand complexes. implications for drug design and signal transduction Angew. Chem. Int. Ed. Engl. 41:2002;3767-3774
16. Gottschalk K.E., Kessler H. Evidence for hetero-association of transmembrane helices of integrins. FEBS Lett. 557:2004;253-258
17. Gottschalk K.E., Adams P.D., Brunger A.T., Kessler H. Transmembrane signal transduction of the alpha(IIb)beta(3) integrin. Protein Sci. 11:2002;1800-1812. a
18. Gottschalk K.E., Gunther R., Kessler H. A three-state mechanism of integrin activation and signal transduction for integrin alpha(v)beta(3). Chembiochem. 3:2002;470-473. b
19. Gratkowski H., Lear J.D., DeGrado W.F. Polar side chains drive the association of model transmembrane peptides. Proc. Natl. Acad. Sci. USA. 98:2001;880-885
20. Hughes P.E., Diaz-Gonzalez F., Leong L., Wu C., McDonald J.A., Shattil S.J., Ginsberg M.H. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J. Biol. Chem. 271:1996;6571-6574
21. Hynes R.O. Integrins. bidirectional, allosteric signaling machines Cell. 110:2002;673-687
22. Jorgensen W., Tirado-Rives J. The OPLS potential function for proteins, energy minimization for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 110:1988;1657-1666
23. Kim M., Carman C.V., Springer T.A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science. 301:2003;1720-1725
24. Kochva U., Leonov H., Arkin I.T. Modeling the structure of the respiratory syncytial virus small hydrophobic protein by silent-mutation analysis of global searching molecular dynamics. Protein Sci. 12:2003;2668-2674
25. Lear J.D., Gratkowski H., Adamian L., Liang J., DeGrado W.F. Position-dependence of stabilizing polar interactions of asparagine in transmembrane helical bundles. Biochemistry. 42:2003;6400-6407
26. Li R., Babu C.R., Lear J.D., Wand A.J., Bennett J.S., DeGrado W.F. Oligomerization of the integrin alphaIIbbeta3. roles of the transmembrane and cytoplasmic domains Proc. Natl. Acad. Sci. USA. 98:2001;12462-12467
27. Li R., Mitra N., Gratkowski H., Vilaire G., Litvinov R., Nagasami C., Weisel J.W., Lear J.D., DeGrado W.F., Bennett J.S. Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations. Science. 300:2003;795-798
28. Liddington R.C. Will the real integrin please stand up? Structure (Camb). 10:2002;605-607
29. Lloyd A.W. alpha(4)beta(1) integrin inhibitors. Drug Discov. Today. 4:1999;186
30. MacKenzie K.R., Prestegard J.H., Engelman D.M. A transmembrane helix dimer. structure and implications Science. 276:1997;131-133
31. Marinelli L., Lavecchia A., Gottschalk K.E., Novellino E., Kessler H. Docking studies on alphavbeta3 integrin ligands. pharmacophore refinement and implications for drug design J. Med. Chem. 46:2003;4393-4404
32. Mousa S.A. Anti-integrin as novel drug-discovery targets. potential therapeutic and diagnostic implications Curr. Opin. Chem. Biol. 6:2002;534-541
33. Partridge A.W., Melnyk R.A., Deber C.M. Polar residues in membrane domains of proteins. molecular basis for helix-helix association in a mutant CFTR transmembrane segment Biochemistry. 41:2002;3647-3653
34. Raguse J.D., Gath H.J., Bier J., Riess H., Oettle H. Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour. Oral Oncol. 40:2004;228-230
35. Russ W.P., Engelman D.M. The GxxxG motif. a framework for transmembrane helix-helix association J. Mol. Biol. 296:2000;911-919
36. Schneider D., Engelman D.M. GALLEX, a measurement of heterologous association of transmembrane helices in a biological membrane. J. Biol. Chem. 278:2003;3105-3111
37. Schneider D., Engelman D.M. Involvement of transmembrane domain interactions in signal transduction by a/b integrins. J. Biol. Chem. 279:2004;9840-9846. Published online December 16, 2003. 10.1074/jbc.M312749200
38. Scibelli A., Tafuri S., Alimenti E., Belisario M.A., Della Morte R., Staiano N. Biochemical analysis of the molecular mechanism of action of natural integrin inhibitors. Vet. Res. Commun. 27:2003;627-630
39. Senes A., Gerstein M., Engelman D.M. Statistical analysis of amino acid patterns in transmembrane helices. the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions J. Mol. Biol. 296:2000;921-936
40. Smith J.W. Cilengitide Merck. Curr. Opin. Investig. Drugs. 4:2003;741-745
41. Takagi J., Strokovich K., Springer T.A., Walz T. Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J. 22:2003;4607-4615
42. van Well R.M., Overkleeft H.S., van der Marel G.A., Bruss D., Thibault G., de Groot P.G., van Boom J.H., Overhand M. Solid-phase synthesis of cyclic RGD-furanoid sugar amino acid peptides as integrin inhibitors. Bioorg. Med. Chem. Lett. 13:2003;331-334
43. Vinogradova O., Haas T., Plow E.F., Qin J. A structural basis for integrin activation by the cytoplasmic tail of the alpha IIb-subunit. Proc. Natl. Acad. Sci. USA. 97:2000;1450-1455
44. Vinogradova O., Velyvis A., Velyviene A., Hu B., Haas T., Plow E., Qin J. A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. Cell. 110:2002;587-597
45. Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L., Joachimiak A., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science. 294:2001;339-345
46. Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science. 296:2002;151-155
47. Xiong J.P., Stehle T., Goodman S.L., Arnaout M.A. New insights into the structural basis of integrin activation. Blood. 102:2003;1155-1159
48. Zhou F.X., Cocco M.J., Russ W.P., Brunger A.T., Engelman D.M. Interhelical hydrogen bonding drives strong interactions in membrane proteins. Nat. Struct. Biol. 7:2000;154-160
49. Zhou F.X., Merianos H.J., Brunger A.T., Engelman D.M. Polar residues drive association of polyleucine transmembrane helices. Proc. Natl. Acad. Sci. USA. 98:2001;2250-2255